Predictive gene expression profile for adjuvant taxane benefit in breast cancer in the MATADOR trial

Autor: Mark Opdam, Annelot G.J. van Rossum, Marlous Hoogstraat, Gergana Bounova, Hugo M. Horlings, Erik van Werkhoven, Ingrid A.M. Mandjes, A. Elise van Leeuwen – Stok, Sander Canisius, Harm van Tinteren, Alex L.T. Imholz, Johanneke E.A. Portielje, Monique E.M.M. Bos, Sandra Bakker, Jelle Wesseling, Lennart Kester, Jacco van Rheenen, Emiel J. Rutgers, Renee X. de Menezes, Lodewyk F.A. Wessels, Marleen Kok, Hendrika M. Oosterkamp, Sabine C. Linn, Marcel Soesan, Rianne M. Oosterkamp, Frank Jeurissen, Nir Weijl, Karin J. Beelen, Aart van Bochove, Gerty de Klerk, Suzan Vrijaldenhoven, Annette van der Velden, Hiltje de Graaf, Marielle Smeets, Jetske Meerum Terwogt, Jolanda Schrama, Philomeen Kuijer, Hanneke Wilmink, Ronald Hoekstra, Judith Kroep, Hans F.M. Pruijt, Leander van Gerven, Allert H. Vos, Frans Erdkamp, Willemien G. van Leeuwen-Breuk, Alexander de Graeff

Publikováno v: iScience, Vol 27, Iss 8, Pp 110425- (2024)

Summary: The primary objective of the prospective, randomized, multicenter, phase 3 biomarker Microarray Analysis in breast cancer to Taylor Adjuvant Drugs Or Regimens trial (MATADOR: ISRCTN61893718) is to generate a gene expression profile that can

Externí odkaz: https://doaj.org/article/3dae747c44804a5fafa1281b33a3c21c

Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial

Autor: Andrzej Piwowar, Fransje Aa Valster, Jeffrey P.B.M. Braak, Marije Ie Appels, Frits van Coevorden, Niels H Nielsen, Johanna E.A. Portielje, Jeroen Buijsen, Petra Flygare, Marije Slingerland, Nicole C.T. van Grieken, Jetske M. Meerum Terwogt, Maartje Los, Mattias Elmlund, Henk Boot, Rob L. H. Jansen, Johanna W. van Sandick, A. Haringhuizen, Johannes J. Bonenkamp, Harm van Tinteren, Edwin P.M. Jansen, Henk H. Hartgrink, Jaap De Boer, Anouk K. Trip, Ge Jpm Jonkers, Marie Louise Jespersen, Cecillia Lagerbäck, Per Edlund, Marco B Polée, Mats Perman, J (Hans)-Martin Mb Otten, Marjan A Van Dijk, Danny Houtsma, A (Bert) Jan Ten Tije, Arnold Baars, Olaf Jl Loosveld, Maud M. Geenen, Maarten C.C.M. Hulshof, Gerrit-Jan Veldhuis, Erik W Muller, Geert-Jan Creemers, Annelie Je Vulink, Quirijn A. J. Eijsbouts, Annerie Slot, Diane Grootenboers, Hein Putter, Ellen M Hendriksen, Maurice J.C. van der Sangen, Fabiënne A. R. M. Warmerdam, Tom Rozema, HA A. Maurits Swellengrebel, Henk K Van Halteren, Ate van der Gaast, Marcel Verheij, Richard Van Hilligersberg, Helene Hörberg, Pehr Lind, Annemieke Cats, Cornelis J.H. van de Velde, Jitty M Smit, Alex L. T. Imholz, Donald L. van der Peet, Aart Van Bochove, Henk M.W. Verheul, Adelheid Me Van der Torren-Conze, Frans L. G. Erdkamp, Dick Johan van Spronsen, Mark I. van Berge Henegouwen, Ernst Jan Spillenaar Bilgen, Johanna Mgh Van Riel, Marien O Den Boer, Hanneke W. M. van Laarhoven, Marjolein Em Rentinck, Ron C Rietbroek, Bengt Johansson, David Borg, Anders Johnsson, Aart Beeker, Reinoud J. B. Blaisse, Miriam Koopman, Daan Ten Bokkel Huinink, Karen J. Neelis, Elma Meershoek-Klein Kranenbarg, Djamila Boerma, Heleen M. Ceha, Bea C Tanis, Marie-Cecile Jc Legdeur, O Aart Van Dobbenburgh, Steven Vanhoutvin, Sjoerd Hovenga, Karolina Sikorska, Pètra M Braam, H Pieter van den Berg, Huub van der Mijle, Marianne Nordsmark, Bengt Glimelius

Publikováno v: lancet oncology, 19(5), 616-628. Lancet Publishing Group
CRITICS investigators 2018, ' Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial ', The Lancet Oncology, vol. 19, no. 5, pp. 616-628 . https://doi.org/10.1016/S1470-2045(18)30132-3
Lancet Oncology, 19, 5, pp. 616-628
CRITICS investigators 2018, ' Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS)-an international, open-label, randomised phase 3 trial ', The Lancet Oncology, vol. 19, no. 5, pp. 616-628 . https://doi.org/10.1016/S1470-2045(18)30132-3
Lancet oncology, 19(5), 616-628. Elsevier Science
Lancet Oncology, 19, 616-628
The Lancet Oncology, 19(5), 616-628
The Lancet Oncology, 19(5), 616-628. Lancet Publishing Group

Item does not contain fulltext BACKGROUND: Both perioperative chemotherapy and postoperative chemoradiotherapy improve survival in patients with resectable gastric cancer from Europe and North America. To our knowledge, these treatment strategies hav

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b21019f3b155741c37a17771cdb957cb
https://pure.amc.nl/en/publications/chemotherapy-versus-chemoradiotherapy-after-surgery-and-preoperative-chemotherapy-for-resectable-gastric-cancer-critics-an-international-openlabel-randomised-phase-3-trial(8c4f223a-519d-480e-ad66-3d7eaea704e6).html

Effect of Low-Intensity Physical Activity and Moderate- to High-Intensity Physical Exercise During Adjuvant Chemotherapy on Physical Fitness, Fatigue, and Chemotherapy Completion Rates: Results of the PACES Randomized Clinical Trial

Autor: Marianne de Maaker-Berkhof, Jeanette A.J.H. Hellendoorn-van Vreeswijk, Simone M. van den Heiligenberg, Neil K. Aaronson, Jolanda Schrama, Laurien M. Buffart, Maud M. Geenen, Carolien H. Smorenburg, Aart van Bochove, Gabe S. Sonke, Jetske M. Meerum Terwogt, Epie Boven, Edwin Geleijn, Willem H. van Harten, Martijn M. Stuiver, Hanna van Waart, Jacobien M. Kieffer, Vera Lustig

Publikováno v: Journal of clinical oncology, 33(17), 1918-1927. American Society of Clinical Oncology
Journal of clinical oncology, 33(17), 1918-1929. American Society of Clinical Oncology
Journal of Clinical Oncology, 33(17), 1918-1927. American Society of Clinical Oncology
van Waart, H, Stuiver, M M, van Harten, W H, Geleijn, E, Kieffer, J M, Buffart, L M, de Maaker-Berkhof, M, Boven, E, Schrama, J, Geenen, M M, Terwogt, J M M, Van Bochove, A, Lustig, V, van den Heiligenberg, S M, Smorenburg, C H, Hellendoorn-van Vreeswijk, J A J H, Sonke, G S & Aaronson, N K 2015, ' Effect of Low-Intensity Physical Activity and Moderate-to High-Intensity Physical Exercise During Adjuvant Chemotherapy on Physical Fitness, Fatigue, and Chemotherapy Completion Rates: Results of the PACES Randomized Clinical Trial ', Journal of Clinical Oncology, vol. 33, no. 17, pp. 1918-1927 . https://doi.org/10.1200/JCO.2014.59.1081

Purpose We evaluated the effectiveness of a low-intensity, home-based physical activity program (Onco-Move) and a moderate- to high-intensity, combined supervised resistance and aerobic exercise program (OnTrack) versus usual care (UC) in maintaining

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b04f47c8177df110ac2d07ac143472e
https://doi.org/10.1200/jco.2014.59.1081

Weekly docetaxel in metastatic breast cancer patients: No superior benefits compared to three-weekly docetaxel

Autor: Gert A. van Deijk, Linda de Munck, Anneke M. Westermann, Willem M. Smit, Geert-Jan Creemers, Carolien P. Schröder, Willemijn Vader, Zoran Erjavec, Pax H.B. Willemse, Aart van Bochove, Hiltje de Graaf, Jacqueline M. Stouthard

Publikováno v: European journal of cancer (Oxford, England, 47(9), 1355-1362. Elsevier Limited
European Journal of Cancer, 47(9), 1355-1362. ELSEVIER SCI LTD

Background: In anthracycline-pretreated metastatic breast cancer (MBC) patients, it is unknown whether weekly single-agent docetaxel is preferable to 3-weekly docetaxel regarding its toxicity and efficacy profile.Patients and methods: In this multice

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1a3d7c2d465aa750ac0500a456cb69b
https://doi.org/10.1016/j.ejca.2010.12.018

Impact of age and comorbidity on survival in colorectal cancer

Autor: Elmer E, van Eeghen, Sandra D, Bakker, Aart, van Bochove, Ruud J L F, Loffeld

Publikováno v: Journal of gastrointestinal oncology. 6(6)

Patients with colorectal cancer are often excluded from clinical trials based on age or a poor performance score. However, 70% of colorectal cancer is diagnosed in patients over 65. Evaluation on the influence of age and comorbidity on survival and c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::874151de2979ae6c0deac9567ac6c585
https://pubmed.ncbi.nlm.nih.gov/26697191